| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
774 |
697 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
627 |
560 |
$48K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
636 |
567 |
$39K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
186 |
175 |
$16K |
| 94760 |
|
206 |
186 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
425 |
256 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
235 |
207 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
62 |
45 |
$504.40 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
20 |
16 |
$489.52 |
| 87807 |
|
31 |
29 |
$307.78 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
30 |
24 |
$192.66 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
17 |
14 |
$47.02 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17 |
12 |
$23.37 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
15 |
12 |
$8.00 |
| S9083 |
Global fee urgent care centers |
66 |
62 |
$0.00 |
| 99000 |
|
60 |
56 |
$0.00 |